Total Funding
85
43
Total FundingSeed raised
Growth Score
-6 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
115253
ImCare Biotech is a provider of quality diagnostic and pharmaceutical products for the treatment of cancers.
- Xuanyong Lu: President and CSO
- Aaron Yefei Lu: CEO
About the Company
ImCare Biotech is a biotechnology company that provides diagnostic and pharmaceutical products intended to use for the treatment of cancers, viral infections, and other long-term illnesses. The company’s primary products in development are innovative diagnostic biomarkers as well as developmental drugs for the treatment of liver diseases such as
hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). It aims to improve the standard of care for patients and their loved ones. With research and innovation as the heart of the company, it hopes to use deliver high-quality commercial products through smart and focused product development.
ImCare Biotech was founded in 2011 and is headquartered in Doylestown, Pennsylvania.
